Label-Free Peptide Nucleic Acid-Based Electrocatalytic Biosensor Coupled with EXPAR for Ultrasensitive Detection of miR-181b
Biosensors · 20.11.2026 · 16 (11) · 672
DOI: 10.3390/bios16110672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, online erschienen am 20.11.2026. Verfasst von Guanxu Chen und 7 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Joint Funds for the Innovation of Science and Technology, Fujian Province, Fujian Medical University.
Abstract (Originalsprache)
Osteosarcoma (OS) is the most common primary malignant bone tumor in adolescents. Diagnosis usually comes late because micrometastases are hard to see on imaging or in biopsy specimens. Exosomal microRNAs survive well in body fluids and have therefore become popular markers for liquid biopsy. miR-181b is abnormally expressed in OS, yet it occurs at low levels in body fluids and differs from miR-181a, miR-181c, and miR-181d by only a few bases. Measuring it demands both high sensitivity and high specificity. Here, we describe a label-free electrocatalytic electrochemical biosensor that pairs a peptide nucleic acid (PNA) capture probe with the exponential amplification reaction (EXPAR). A 3′-thiolated PNA probe was attached to a gold electrode by rapid freezing-assisted Au–S bonding. EXPAR converted the target into single-stranded DNA, which bound PNA and a signal probe to form a sandwich. PNA carries a neutral backbone, whereas DNA is negatively charged, so [Ru(NH3)6]3+ was adsorbed onto the sandwich by electrostatic attraction. [Fe(CN)6]3− then re-oxidized the reduced Ru complex in a catalytic cycle, and square wave voltammetry recorded the current. Under optimized conditions, the sensor responded linearly to miR-181b from 1 fM to 1 nM, with an experimental detection limit of 1 fM. It separated miR-181b from miR-181a, miR-181c, and miR-181d, and the inter-day RSD over 3 consecutive days was 4.34% (n = 9; three electrodes per day). After 6 days of storage in PBS at 4 °C, the electrodes still delivered 83.8% of their initial response. All measurements used synthetic miR-181b. Clinical validation and long-term shelf-life stability have not yet been established.
Förderung
- National Natural Science Foundation of China
- Joint Funds for the Innovation of Science and Technology, Fujian Province
- Fujian Medical University
- Financial Science and Technology Special Fund of Fujian Province
Zitieren
APA
Chen, G., Zhou, J., Feng, Q., Zhao, Q., Zhang, C., Fang, Y., Chen, J., & Zhong, G. (2026). Label-Free Peptide Nucleic Acid-Based Electrocatalytic Biosensor Coupled with EXPAR for Ultrasensitive Detection of miR-181b. Biosensors, 16(11), 672. https://doi.org/10.3390/bios16110672
Vancouver
Chen G, Zhou J, Feng Q, Zhao Q, Zhang C, Fang Y, et al. Label-Free Peptide Nucleic Acid-Based Electrocatalytic Biosensor Coupled with EXPAR for Ultrasensitive Detection of miR-181b. Biosensors. 2026;16(11):672. doi:10.3390/bios16110672
BibTeX
@article{Chen2026,
author = {Chen, Guanxu and Zhou, Jingwei and Feng, Qianqian and Zhao, Qixiang and Zhang, Chuiju and Fang, Yuxi and Chen, Jinyuan and Zhong, Guangxian},
title = {Label-Free Peptide Nucleic Acid-Based Electrocatalytic Biosensor Coupled with EXPAR for Ultrasensitive Detection of miR-181b},
journal = {Biosensors},
year = {2026},
volume = {16},
number = {11},
pages = {672},
doi = {10.3390/bios16110672}
}
EUVIMED